EFFECT OF VISCERAL MANIPULATION ON VARIATION IN ALANINE TRANSAMINASE LEVELS AND LIVER MOBILITY USING ULTRASONOGRAPY IN INDIVIDUALS WITH FATTY LIVER: AN EXPERIMENTAL STUDY

EFFECT OF VISCERAL MANIPULATION ON VARIATION IN LIVER ENZYMES LEVELS AND LIVER MOBILITY IN INDIVIDUALS WITH FATTY LIVER: AN EXPERIMENTAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059093

Enrollment

Registered

2023-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K70-K77- Diseases of liver

Interventions

Intervention1: VISCERAL MANIPULATION: INDIVIDUALS WITH STAGE 1 AND 2 FATTY LIVER WILL BE GIVEN THE INTERVENTION I.E VISCERAL MANIPULATION FOR 2 WEEKS ON ALTERNATE DAYS. Control Intervention1: Visceral

Eligibility

Inclusion criteria

Inclusion criteria: 1-Alanine transaminase levels more than 35 -79 U/L for men and 31-55 U/L for women. 2-The controlled Attenuation parameter (CAP) score more than 238dB/m on ultrasonograpy 3-Stage 1 and 2 of fatty liver

Exclusion criteria

Exclusion criteria: 1-Liver cirrhosis 2-Jaundice 3-Rib fracture 4-COPD 5-Hepatitis A,B,C 6-Amyloidosis 7-Hepatomegaly 8-Subject on any medication like antibiotics

Design outcomes

Primary

Measure	Time frame
1.Ultrasonograpy of liver Timepoint: Baseline and at 2 weeks	—

Secondary

Measure	Time frame
Alanine transaminase testTimepoint: Baseline & at 2 weeks	—

Countries

India

Contacts

Public ContactNeha kopper

KLE INSTITUTE OF PHYSIOTHERAPY

santoshmetgud@klekipt.edu.in9164646484

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026